Delivery Order SPE2DE24D0013-SPE2D625F2XAU
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $22,926.50 by the Medical Supply Chain division of the Department of Defense on September 8, 2025, with a completion date of September 15, 2025. The delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a continuation of Cepheid's...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,471.70 by the Medical Supply Chain division of the Defense Department on August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract award references XPRSARS-COV2-10, indicating the delivery order...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, has been awarded a delivery order valued at $8,533.57 under contract XPRS4PLEX-10 by the Medical Supply Chain, a Defense agency entity. The award, issued on August 29, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed-price pricing and does not include a set-aside designation. Performance will be conducted at Cepheid's Sunnyvale facility. This delivery order represents...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, has been awarded a delivery order valued at $1,605.00 under contract GXMRSA-NXG-10, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is funded by the Defense Medical Supply Chain, a defense-focused federal agency. The award represents Cepheid's continued provision of molecular diagnostic technologies and services to the...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $14,960 by the Defense Department's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 21, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions, specifically molecular reagents and assays for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. This award carries...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,024 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, contract number 4569079036, is scheduled for completion by August 20, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no set-aside designation, allowing the company to compete on an unrestricted basis....
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2XAUDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $6,390 on September 9, 2025, by the Defense Department's Medical Supply Chain office. The delivery order, designated XPRS4PLEX-10, has an ultimate completion date of September 16, 2025, and involves performance at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents a discrete procurement action under the company's broader federal contract portfolio with defense and Veterans Affairs entities. This delivery order is consistent with Cepheid's established role as a primary supplier of molecular diagnostic systems, reagents, and testing solutions to federal healthcare agencies. The company maintains two significant Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs—one valued at $32.8 million through September 2030 and another valued at $2.5 million—which enable ongoing procurement of PCR testing solutions and diagnostic assays for conditions including COVID-19, influenza, respiratory syncytial virus, and tuberculosis. The modest value of this particular delivery order reflects routine procurement activity under Cepheid's existing federal contract vehicles to support ongoing diagnostic testing requirements across the Defense Department's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 9/9/25 |